A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma

Clinical trial NCT03558412 · UNKNOWN

Trial details

NCT number: NCT03558412
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

T-lymphoblastic Lymphoma

Start date: 2018-06-01
Primary completion: 2019-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.